Glucagon-l相关论文
的病理生理变化有关....
胰升血糖素样肽-1(GLP-1)是肠道因进食而分泌的促胰岛素分泌肽,最早发现的胰升血糖素样肽-1是其受体(GLP-1R)激动剂。GLP-1R及GLP-......
[目的]比较利拉鲁肽和艾塞那肽治疗2型糖尿病(T2DM)的有效性和安全性.[方法]78例T2DM患者分为两组:利拉鲁肽组采用利拉鲁肽联合二......
目的：探讨磷脂酰肌醇3激酶（phosphatidylinositol 3-kinase,PI3K）抑制剂LY294002与胰升血糖素样肽-1（glucagonlike peptide-1,GLP-1）拟......
The number of patients with osteoporosis and diabetesis rapidly increasing all over the world. Bone is recentlyrecognize......
